Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

Hubei Gedian Humanwell Pharmaceutical Co., Ltd. (*) is a pharmaceutical enterprise wholly invested by the listed company Humanwell Healthcare (Group) Co., Ltd. (stock code: 600079, ranked 36th among the "Top 100 Pharmaceutical Industries in China", among the "Top 50 Core Competitiveness of Pharmaceutical Listed Companies", and 1st among the "Top 10 Pharmaceutical Manufacturers in Hubei Province"). The company specializes in the research and development, production, and sales of steroidal active pharmaceutical ingredients, reproductive health drugs, and anti-tumor drugs. It is located in the Gedian Economic and Technological Development Zone on the outskirts of Wuhan. The company's factory covers an area of 80,000 square meters, with a building area of 15,000 square meters, registered capital of 128.255 million yuan, total assets of 390 million yuan, and annual sales of 300 million yuan. The company is among the first batch of recognized national high-tech enterprises, possesses an advanced comprehensive laboratory and a professional pharmaceutical research center, has independently developed multiple new drug varieties, and has a solid technical reserve and strong R&D capabilities. In recent years, Gedian Humanwell Pharmaceutical has been committed to building a complete industrial chain in the reproductive health field, and has successively invested in and established 6 subsidiaries focusing on steroidal hormone drugs and various distinctive directions in the reproductive health industry: among them, Wuhan Humanwell Medical Equipment Co., Ltd. (registered capital of 20 million yuan) focuses on the market promotion, sales, and after-sales service of international cutting-edge medical equipment and medical device products, deepening its presence in the reproductive health medical device field; Wuhan Jiulong Humanwell Pharmaceutical Co., Ltd. (registered capital of 50.08 million yuan, covering an area of 71,928 square meters) is building a production base for fertility regulation drugs with family planning drugs as its leading products, ranking among the top three in the country in terms of profitability and product scale; Hubei Humanwell Huachi Pharmaceutical Chemical Co., Ltd. (registered capital of 10 million yuan) is engaged in the production and sales of upstream raw materials for steroidal hormones, diosgenin diene, and their pharmaceutical intermediates, committed to becoming a mainstream supplier of diosgenin diene series products in China and even globally, and striving to become a leader in the production and sales of pharmaceutical chemical active pharmaceutical ingredients; Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. (registered capital of 10 million yuan, covering an area of 74,659 square meters) is engaged in the production and sales of pharmaceutical intermediates, chemical products, and plant extracts, striving to become a mainstream supplier of diosgenin and its derivatives nationwide and globally; Hubei Gedian Humanwell Pharmaceutical Excipients Co., Ltd. (registered capital of 50 million yuan, covering an area of 66,600 square meters) specializes in the research and development, production, and sales of pharmaceutical excipient products; Wuhan Jiulong Pharmaceutical Co., Ltd. (registered capital of 10 million yuan), relying on the resource advantages of the East Lake Bonded Zone and leveraging Gedian Humanwell's broadening and extension of existing product lines, is gradually becoming a modern advanced commercial platform for "introducing externally and extending internally" in the pharmaceutical industry cluster of the Central South region. The company currently has 800 employees and a marketing team of more than 300 people, with a marketing network covering 26 provinces, cities, autonomous regions, and municipalities directly under the Central Government across the country. The company actively expands overseas business in Southeast Asia, the European Union, South America, the Middle East, and Africa. The sunny, positive, young, and efficient employee team, strong R&D capabilities, and increasingly perfect domestic and overseas marketing network have established a good corporate image among society and pharmaceutical industry peers, and have won the trust and support of all sectors of society. With the field of human reproductive health as its main direction, the company has gradually developed into a banner of China's steroidal family planning drug industry. An aircraft carrier in the field of steroidal hormone drugs and the reproductive health industry is setting sail.